Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.56 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 7/20 | 0.46 |
| ▸ | PPARD | Q03181 | 7/20 | 0.46 |
| ▸ | PPARA | Q07869 | 7/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11017002 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL3661831 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL7640632 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL6836310 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL3033182 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL7504525 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL2531077 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL1312624 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL10704488 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 | |
| SCHEMBL9629897 | 1.00 | SPHK2 (0.56) | SPHK2SPHK1CES2CES1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3024036-B1 | MANUFACTURING METHOD FOR CI(G)S NANOPARTICLES FOR MANUFACTURING LIGHT-ABSORBING LAYER, AND CI(G)S NANOPARTICLES MANUFACTURED USING SAME | LG CHEMICAL LTD (KR) | 2018-09-05 | — | — | EP | claimed |
| EP-0035208-B1 | METHOD OF MAKING VISIBLE STATIONARY HEAT TRANSFER COEFFICIENT FIELDS BY PHOTOCHEMICAL MEANS | SIEMENS AKTIENGESELLSCHAFT (DE) | 1985-05-29 | — | — | EP | claimed |
| US-20240043808-A1 | Screenable Liver Disease Models and Methods | INSPHERO AG (CH) | 2024-02-08 | — | — | US | disclosed |
| WO-2023091173-A1 | METHODS OF LIVER DISEASE TREATMENT | HUDNALL MICHAEL (US) | 2023-05-25 | — | — | WO | disclosed |
| WO-2022115488-A1 | IMMUNOGENIC NANOVESICLES FOR CANCER IMMUNOTHERAPY | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-06-02 | — | — | WO | disclosed |
| US-11252984-B2 | Methods of liver disease treatment | HEPASSURE, INC. | 2022-02-22 | — | — | US | disclosed |
| US-20200332300-A1 | MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS | AADIGEN, LLC | 2020-10-22 | — | — | US | disclosed |
| EP-3559212-A1 | SCREENABLE LIVER DISEASE MODELS AND METHODS | Insphero AG (CH) | 2019-10-30 | — | — | EP | disclosed |
| US-20190316093-A1 | SCREENABLE LIVER DISEASE MODELS AND METHODS | INSPHERO AG (CH) | 2019-10-17 | — | — | US | disclosed |
| EP-3424511-A1 | MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS | Aadigen, LLC (US) | 2019-01-09 | — | — | EP | disclosed |
| US-20180187199-A1 | MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS | AADIGEN LLC (US) | 2018-07-05 | — | — | US | disclosed |
| CN-1835889-A | Process for producing hydroxylamine | SHOWA DENKO KK (JP) | 2006-09-20 | — | — | CN | disclosed |
| WO-2006062178-A2 | STABILIZER FOR HYDROXYLAMINE, METHOD FOR STABILIZING HYDROXYLAMINE, AND STABILIZED HYDROXYLAMINE SOLUTION | SHOWA DENKO K.K. (JP) | 2006-06-15 | — | — | WO | disclosed |
| EP-1663862-A2 | PROCESS FOR PRODUCING HYDROXYLAMINE | Showa Denko K.K. (JP) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005016817-A2 | PROCESS FOR PRODUCING HYDROXYLAMINE | SHOWA DENKO K. K. (JP) | 2005-02-24 | — | — | WO | disclosed |
| EP-1296714-A2 | METHODS FOR ENHANCING ANTIBODY-INDUCED CELL LYSIS AND TREATING CANCER | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2003-04-02 | — | — | EP | disclosed |
| US-20030026801-A1 | Methods for enhancing antibody-induced cell lysis and treating cancer | PFIZER INC. | 2003-02-06 | — | — | US | disclosed |
| US-20020156033-A1 | Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer | COLEY PHARMACEUTICAL GROUP, INC. | 2002-10-24 | — | — | US | disclosed |
| WO-2001097843-A2 | METHODS FOR ENHANCING ANTIBODY-INDUCED CELL LYSIS AND TREATING CANCER | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2001-12-27 | — | — | WO | disclosed |
| US-3948892-A | 2-Alkoxy(and 2-amino)-3-amino-2-heterocyclic-thiopropanamides | SMITHKLINE CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |